19 results
8-K
EX-10.1
LCTX
Lineage Cell Therapeutics Inc
15 Sep 21
Departure of Directors or Certain Officers
7:00am
or net operating profit; (xxx) workforce diversity; (xxxi) growth of net income or operating income; (xxxii) billings; and (xxxiii) any other measures
8-K
EX-99.1
lowk 4u13bd0el
21 Apr 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
7kgikjbbp3et
19 Sep 12
BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2012
12:00am
8-K
bhvop6hqbg
27 Feb 09
BioTime's Subsidiary Enters Agreement Adding New Embryonic Stem Cell Lines to Its Product Portfolio
12:00am
8-K
EX-99.1
bymy7ekw4nr1jxf3d
27 Feb 09
BioTime's Subsidiary Enters Agreement Adding New Embryonic Stem Cell Lines to Its Product Portfolio
12:00am
- Prev
- 1
- Next